Supplemental Material is available online (<https://doi.org/10.1289/EHP6174>).

Where authors are identified as personnel of the International Agency for Research on Cancer/World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer/World Health Organization.

The authors declare they have no actual or potential competing financial interests.

**Note to readers with disabilities:** *EHP* strives to ensure that all journal content is accessible to all readers. However, some figures and Supplemental Material published in *EHP* articles may not conform to [508 standards](http://ehp.niehs.nih.gov/accessibility/) due to the complexity of the information being presented. If you need assistance accessing journal content, please contact <ehponline@niehs.nih.gov>. Our staff will work with you to assess and meet your accessibility needs within 3 working days.

Introduction {#s1}
============

Transportation-related noise (including road traffic, railway, and aircraft noise) and air pollution \[including nitrogen dioxide (${NO}_{2}$) and particulate matter (PM) with aerodynamic diameter $< 2.5\;\mu m$ (${PM}_{2.5}$)\] both make the greatest contribution to the global environmental burden of disease ([@c43]; [@c48]; [@c118]). Both exposure groups have been linked to cross-systemic phenotypes, including respiratory ([@c4]; [@c33]; [@c54]), cardiovascular ([@c14]; [@c37]; [@c40]; [@c52]; [@c64]), and metabolic diseases ([@c35]; [@c124]); cancers ([@c10]; [@c49]; [@c95]); and neurological disturbances ([@c24]; [@c107]; [@c125]). The potential mechanisms linking air pollution and these phenotypes include inflammatory, immune, and oxidative stress responses following inhalation ([@c83]), whereas noise is thought to act through annoyance reactions, sleep disturbances, stress, and activation of the hypothalamic--pituitary--adrenal (HPA) axis and sympathetic nervous system, with subsequent release of stress hormones and inflammatory molecules ([@c27]).

DNA methylation alterations may mediate part of the physiological and biochemical changes leading from these traffic-related exposures to their associated preclinical and clinical phenotypes. Increasing evidence has linked short- and long-term air pollution exposure to various measures of DNA methylation in both children and adults ([@c1]; [@c28]; [@c45]; [@c46]; [@c68]; [@c81]; [@c90]; [@c93], [@c92]; [@c103]). Although findings from these studies were largely inconsistent with regard to single Cytosine-phosphate-Guanine (CpG) sites, the systematic review by Alfano et al. ([@c6]) highlighted that air pollution was consistently linked to global hypomethylation in children ([@c15]; [@c17]; [@c60]) and in adults ([@c29]; [@c30]) and accelerated epigenetic aging in adults ([@c86], [@c87]; [@c121]). Overarching epigenomic effects of air pollution identified across these studies include inflammation, mitochondrial and DNA damage responses, and accelerated biological aging ([@c6]).

Transportation noise, like air pollution, may also influence health outcomes via DNA methylation. First, they might share mechanistic pathways, because there is growing evidence for the inflammatory and oxidative downstream effects of noise exposure ([@c27]; [@c83]). Second, oxidative DNA damage, a correlate of altered DNA methylation and gene expression ([@c101]) was linked to occupational noise ([@c12]; [@c85]) and traffic noise ([@c128]). Third, DNA methylation changes were reported for noise-related stressors such as vehicular traffic ([@c25]) and insufficient sleep ([@c44]). Methylation changes were also reported in circadian rhythm genes in conditions of acute sleep loss ([@c19]) and night-shift work ([@c127]). A study investigating brain tissue DNA methylation in relation to noise exposure in animal models reported gene-specific methylation changes, which were in turn associated with metabolic health ([@c47]).

No transportation noise epigenome-wide association study (EWAS) has been performed so far in population-based studies, and previous air pollution EWAS studies did not account for concurrent noise exposure ([@c36]). This partial scope of research is a limitation because both exposures share common sources and might be potential mutual confounders ([@c110]). As demonstrated by previous studies ([@c42]; [@c52]; [@c110]), the effect estimates of air pollution might be overestimated if noise level is unaccounted for, and vice versa. In addition, a parallel consideration of both exposure groups might elucidate directly shared and independent pathways of individual exposures and provide an improved understanding of mechanisms linking these exposures to disease.

In this paper, we aimed within the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults (SAPALDIA) to conduct a multiexposure EWAS (single CpGs and genomic regions) involving long-term exposure to source-specific transportation noise (aircraft, railway, and road traffic) and air pollution (${NO}_{2}$ and ${PM}_{2.5}$);assess in a candidate approach, using *a priori*-curated CpGs, the pathway enrichment for "allostatic load"-related cardio-metabolic, immunological, and renal phenotypes ([@c62]; [@c80]; [@c105]), given that both traffic-related exposures are chronic stressors of several physiological systems;assess in an agnostic approach, the functional pathway and network enrichment of EWAS-derived differentially methylated regions (DMRs); andreplicate previously reported CpGs associated with long-term exposure to ${NO}_{2}$ and ${PM}_{2.5}$ in the LifeLines ([@c28]), EPIC-ITALY and EPIC-NL ([@c93]), and Korean COPD ([@c68]) cohorts.

Methods {#s2}
=======

Study Population {#s2.1}
----------------

The SAPALDIA cohort has been described elsewhere in detail ([@c2]; [@c79]). SAPALDIA is a population-based study that recruited 9,651 adults from 8 geographically diverse Swiss areas (Aarau, Basel, Davos, Geneva, Lugano, Montana, Payerne, and Wald) in 1991 (SAP1) to investigate the respiratory effects of air pollution exposure. The first (SAP2) and second (SAP3) follow-up surveys occurred in 2002 and 2010; included 8,047 and 6,088 participants, respectively; and additionally, assessed cardio-metabolic and quality of life phenotypes. At each survey, participants had physical examinations and health- and lifestyle-related interviews. Measures of transportation noise and air pollution exposures were modeled at participants' residences. At both SAP2 and SAP3, whole blood samples were collected, preprocessed, and stored in a biobank ($- 80{^\circ}C$) for biomarker assessments, including DNA methylation. In the context two SAPALDIA nested studies---Aging Lungs in European Cohorts study (ALEC; [www.alecstudy.org](http://www.alecstudy.org)) and the EXPOsOMICS study ([@c119])---SAP2 and SAP3 repeat blood samples from 987 representative participants (ALEC), and an independent 405 nonsmoking participants (for at least 1 y before SAP2; EXPOsOMICS), were applied toward DNA methylation assessment. The EXPOsOMICS sample was an asthma case--control sample of nonsmokers (204 cases and 201 controls), where the asthma cases had methylation assessed only in the SAP3 blood sample and the controls had methylation assessment in both the SAP2 and SAP3 blood samples. Following exclusions due to methylation data quality and covariate data availability, we included SAP2 data from 972 ALEC and 198 EXPOsOMICS (asthma controls) participants and SAP3 data from 970 ALEC and 402 EXPOsOMICS (204 asthma cases and 198 controls) participants.

The present study therefore includes 1,389 participants contributing 2,542 observations, with an average of 1.8 observations per participant. [Figure 1](#f1){ref-type="fig"} presents the details of participant selection and inclusion. The SAPALDIA study complies with the Declaration of Helsinki. All participants provided informed written consent before participating in any aspect of the SAPALDIA surveys and ethical approvals were obtained from the Swiss Academy of Medical Sciences and the Ethics committees of the participating cantons.

![Selection of participants included in the present study. SAPALDIA: Swiss cohort study on air pollution and lung and heart diseases in adults. ALEC: Aging lungs in European cohorts. ALEC and EXPOsOMICS are European cohort consortia in which SAPALDIA participates. DNA methylation was measured using Illumina Infinium 450K BeadChip and processed in the same manner across the ALEC and EXPOsOMICS samples to derive the residuals of the beta values (corrected for technical bias) of overlapping 430,477 CpGs, which were subsequently applied to the present epigenome-wide association study.](ehp6174_f1){#f1}

Assessment of DNA Methylation {#s2.2}
-----------------------------

DNA methylation was measured in the ALEC and EXPOsOMICS samples separately in different laboratories, but using consistent methodology, using Illumina Infinium 450K BeadChip and processed as previously described ([@c57]; [@c61]). In brief, paired blood samples from the same participant were randomized across the arrays and placed next to each other on the arrays. Dye-bias correction ([@c113]) and absolute methylation level ($\beta$-values, defined as the ratio of methylation intensity over total intensity, with offset of 100) were computed using the minfi R-package (R Development Core Team) ([@c11]). Quality control criteria included call rate $> 95\%$, detection $p$-value $< 10^{- 16}$, sex consistency, autosomal chromosome location of probes, and restriction to probes identified in both ALEC and EXPOsOMICS samples. We applied beta mixture quantile normalization (BMIQ) of the $\beta$-values to correct for the Illumina probe design bias ([@c109]). We further excluded 37,882 CpGs that are cross-reactive or target polymorphic ([@c21]). For technical bias (batch effect) correction, these $\beta$-values were then regressed on the first 30 principal components derived from a principal component analysis of the control probes incorporated on the methylation chip ([@c69]). Figure S1 shows the distributions of the BMIQ-normalized $\beta$-values and technical bias-corrected residuals. In line with previous studies ([@c57]; [@c61]), we applied these residuals (in place of the $\beta$-values) in subsequent EWAS covering 430,477 CpG sites that overlapped between ALEC and EXPOsOMICS samples.

To minimize bias due to extreme values (EVs) of the residuals---the dependent variables in the present EWAS---while retaining the distribution of DNA methylation at the nonskewed CpG sites, we performed modified winsorization of the CpG sites containing EVs. We defined EVs as values lying beyond three times the interquartile range (IQR) below and above the first (Q1) and third quartiles (Q3), respectively ([@c114]). We replaced each EV with the corresponding threshold of detection, in a CpG-specific manner, that is:

If $EV < \left\lbrack {Q1 - \left( {3 \times IQR} \right)} \right\rbrack$, then EV is replaced with the value of $Q1 - \left( {3 \times IQR} \right)$ at the CpG site;

If $EV > \left\lbrack {Q3\, + {\,\left( {3 \times IQR} \right)}} \right\rbrack$, then EV is replaced with the value of $Q3\, + \,\left( {3 \times IQR} \right)$ at the CpG site.

Among the 430,477 included CpGs, 393,397 CpGs (91%) had at least one EV. The EVs comprised 0.04%--22% of observations across the "winsorized" CpG sites. We used these "winsorized" data as the primary outcome variables in subsequent analyses (including EWAS, enrichment, and replication), and only used the "nonwinsorized" data for sensitivity testing of the top CpG signals identified in the EWAS.

Assessment of Transportation Noise Exposure {#s2.3}
-------------------------------------------

As detailed elsewhere ([@c63]), annual average day-evening-night noise level \[Lden, with respective 5 dB and 10 dB penalties for evening (19--23 h) and nighttime (23--07 h; Lnight)\] were calculated for 2001 and 2011 (corresponding to SAP2 and SAP3, respectively), for aircraft, railway, and road traffic noise at the maximum-exposed façade of the residential floors of participants. This calculation was done in the framework of the Short and Long Term Effects of Transportation Noise Exposure (SiRENE) project ([@c99]). Aircraft noise was modeled with the FLULA2 version 4 software ([@c32]) with input data covering four airports in Basel, Geneva, Zurich, and Payerne. Railway noise emission and propagation were modeled using the sonRAIL ([@c112]) and the SEMIBEL ([@c39]) models, respectively, whereas road traffic noise emission and propagation were separately modeled using sonROAD ([@c53]) and StL-86 ([@c38]). Validation of noise calculations was done by comparing the calculated noise levels with measured levels from the field. Taking all measurements into account, a mean Lden difference of $1.6 \pm 5{\, dB}$ was observed ([@c104]). Lden and Lnight values were respectively truncated at $30{\, dB}$ and $20{\, dB}$ for railway and aircraft noise, and $35{\, dB}$ and $25{\, dB}$ for road traffic noise. Calculated Lden and Lnight values below these limits were replaced by the respective truncation values. Participants with truncated values were assigned a truncation indicator (yes/no) for subsequent modeling, in line with previous analyses in the context of the SiRENE study ([@c34]; [@c40]). Given the high correlations of source-specific Lden and Lnight, (Spearman's rank correlation, $r_{\text{aircraft}} = 0.76$, $r_{\text{railway}} = 0.97$, and $r_{\text{road\ traffic}} = 0.99$), and the generally lower Lnight levels (Table S1 and Figure S2); we focused on source-specific Lden as the noise parameters of interest in this EWAS.

Assessment of Air Pollution Exposure {#s2.4}
------------------------------------

Traffic-related air pollutants---${NO}_{2}$ and ${PM}_{2.5}$---were also modeled at participant's residences at SAP2 and SAP3 as outdoor mean exposures. For SAP2, annual mean ${NO}_{2}$ was estimated (year 2003) using a hybrid model that regressed passive sampler measurements against dispersion model estimates, seasonal and climatic variables, as well as traffic and land use characteristics. Adjusted $R^{2}$ of the hybrid model was 0.8 ([@c74]). ${PM}_{2.5}$ was derived from the Swiss PolluMap dispersion model (year 2000). Modeled values were validated against measured values with an $R^{2}$ of 0.9 ([@c51]). For SAP3, ${NO}_{2}$ and ${PM}_{2.5}$ were modeled as average biennial exposures (2010/2011) using land use regression models. The best models were used in each case: the combined ${PM}_{2.5}$ with an adjusted $R^{2}$ of 0.6, and the area-specific ${NO}_{2}$ models with adjusted $R^{2}’s$ of 0.5--0.9 across SAPALDIA study areas ([@c31]). We included both pollutants in our analyses, examining their associations in both single- and multiexposure models.

Assessment of Covariates {#s2.5}
------------------------

At the level of the individual, we considered groups of potential confounders measured at both SAP2 and SAP3, which might be associated with transportation noise, air pollution exposures, and DNA methylome. We considered sociodemographic factors including age (y), sex (male/female), and educational attainment (primary education/secondary education or apprenticeship/tertiary education). We considered lifestyle factors such as smoking status (never/former/current), smoking pack-years (calculated from cigarettes per day and duration of smoking), passive smoking (yes/no), alcohol consumption (beers, wines, liquors and spirits; $\leq 1\text{ glass}/d\text{ or} > 1\text{ glass}/d$), frequency of fruit intake (citrus or noncitrus fruits in any form; $\leq 3\; d/{wk}\text{ or} > 3\; d/{wk}$), vegetable intake (raw or cooked; $\leq 3\; d/{wk}\text{ or} > 3\; d/{wk}$), body mass index (BMI; ${kg}/m^{2}$), and sufficient moderate-to-vigorous physical activity ($\geq 150\text{ min}/{wk}$ of engagement in activities that makes one at least moderately sweat or breathless). To minimize the between-nested study differences, including residual batch effects and asthma status, we considered the contributing nested study (ALEC/EXPOsOMICS) and asthma status, defined as ever having a diagnosis of asthma. We also considered estimates of leukocyte composition for B cells, CD4T cells, CD8T cells, eosinophils, monocytes, natural killer cells, and neutrophils (derived from the DNA methylation data using the "estimatecellcounts" function in the minfi R package ([@c55]; [@c97]), to control the influence of cell proportions on methylation level ([@c3]).

On the contextual scale, we considered some commonly indicated potential confounders of environmental health such as study area, a neighborhood index of socioeconomic position (SEP; %), and greenness index within a $1\text{-}{km}$ residential buffer. SEP was derived from a principal component analysis of household characteristics (education, occupation of household head, occupancy and median rent of household) based on 2001 census data ([@c89]), and assigned to residential geo-coordinates at SAP2 and SAP3. Greenness index was calculated for 2014 as normalized difference vegetation index based on surface reflectance and assigned to participants' geo-coordinates at SAP2 and SAP3 ([@c117]).

Statistical Analyses {#s2.6}
--------------------

### EWAS. {#s2.6.1}

We described the characteristics of included participants by survey and by nested study, summarizing categorical variables as counts and proportions and summarizing continuous variables as medians and IQR. Using the combined sample, we performed EWAS by linear mixed-effects regressions on the "winsorized" technical-bias corrected residuals of 430,477 CpGs, applying random intercepts at the level of participants. We used the "lmer" function of the lme4 R package for the regressions ([@c13]). We performed single- as well as multiexposure EWAS for aircraft, railway, and road traffic Lden, ${NO}_{2}$ and ${PM}_{2.5}$, adjusting for age; sex; education; smoking status; pack-years; passive smoking; fruit, vegetable, and alcohol intake; study area; SEP; greenness index; survey; nested study; asthma; Lden truncation indicator; and Houseman estimates of leukocyte composition in the main model. We identified genome-wide significant CpGs at false discovery rate (FDR) and Bonferroni-corrected $p$-value thresholds of 0.05 and $1.16 \times 10^{- 7}$, respectively.

We tested sensitivity of the top 10 CpGs to further adjustment for the potential mediators BMI and physical activity, which have been associated with transportation noise ([@c8]; [@c41]; [@c100]) and air pollution exposures ([@c7], [@c9]). We further stratified these CpGs by nested study to assess consistency in effect direction, limited these models to participants who reported regular nighttime opening of windows, and assessed the robustness of top signals in models using the "nonwinsorized" methylation data.

We tested for DMRs, using the "dmrcate" function in the DMRcate R package ([@c91]) and the multiexposure EWAS-derived parameters for each CpG as input file. Thus, we performed the DMR analyses using the individual estimates of 430,477 CpGs from the main multiexposure model. We defined DMRs as significant if they contained at least two CpGs, within at least 1,000 base pairs, and had a minimum FDR $p\text{-value} < 0.05$. Except when unannotated, all CpGs and DMRs are reported with gene annotation in parenthesis.

Pathway Enrichment {#s2.7}
------------------

In a candidate pathway approach, we identified previously published EWAS signals for different physiological systems (captured by selected phenotypes) of potential relevance to transportation-related noise and air pollution effects. These systems (phenotypes) included *a*) immunological (C-reactive protein, CRP); *b*) metabolic \[glycemia, insulin secretion/sensitivity, lipoprotein cholesterol, BMI, waist circumference (WC)/visceral adipose tissue mass, and metabolic syndrome\]; *c*) renal (estimated glomerular filtration rate, eGFR); and *d*) cardiovascular and autonomic nervous systems \[blood pressure and cardiac autonomic responses (CAR)\]. For all phenotypes, we curated CpGs from the EWAS atlas ([@c72]), at a $p$-value threshold of $1.10 \times 10^{- 5}$, except for CRP where only the genome-wide significant signals at $p$-value of $1.15 \times 10^{- 7}$ were reported ([@c73]). CpGs that overlapped with those of the SAPALDIA study were finally curated for enrichment analyses (Table S1).

We defined a global "allostatic load" pathway as the entirety of unique CpGs assigned to at least one of the constituent pathways ($n = 1,626$). We applied the Weighted Kolmogorov-Smirnov method ([@c20]) to test for enrichment of the candidate and "allostatic load" pathways using the absolute values of test statistics from multiexposure EWAS. These test statistics from CpGs mapped to the pathway were compared with the empirical null distribution derived by 10,000 permutation samples. If the Kolmogorov-Smirnov test statistic was larger than the 90th percentile of test statistics obtained from the permutation samples after permutation-based multiple testing correction ([@c115]), we declared enrichment for the pathway.

In an agnostic approach, we assessed the functional pathways of exposure-specific differential methylation, using the "Core Analysis" of ingenuity pathway analysis (IPA; Ingenuity Systems) on genes annotated to significant DMRs. For each exposure, we identified the functional pathways that were significantly enriched at $p$-value $< 0.05$, as well as top disease and functional networks related to these pathways.

Replication of Previously Reported Air Pollution--Associated CpGs {#s2.8}
-----------------------------------------------------------------

Using the SAPALDIA EWAS results, we looked up the single- and multiexposure EWAS signals for validation of 22 and 10 previously reported genome-wide significant CpGs for long-term exposure to ${NO}_{2}$ and ${PM}_{2.5}$, respectively. These include ${NO}_{2}$ signals from the LifeLines cohort \[cg04908668, cg14938677, cg00344801, cg18379295, cg25769469, cg02234653, and cg08500171 ([@c28])\], EPIC-ITALY \[cg08120023, cg22856765, cg18164357, cg13918628, cg03870188, cg20939320, cg13420207, cg04914283, cg21156210, cg16205861, cg12790758, and cg18201392 ([@c93])\], and the Korean COPD cohort \[cg05171937, cg06226567, and cg26583725 ([@c68])\]. ${PM}_{2.5}$-associated signals include in cg23890774 from EPIC-ITALY; and cg12575202, cg08630381, cg17629796, cg07084345, cg04319606, cg09568355, cg03513315, cg25489413, and cg00005622 from EPIC-NL ([@c93]). We identified CpGs as replicated in our study if they showed consistent effect direction at nominal $p$-value threshold of 0.05.

Results {#s3}
=======

The characteristics of the study sample at SAP2 and SAP3 are presented in [Table 1](#t1){ref-type="table"}. In general, participants tended to gain weight and smoke less with relatively lower pollutant exposures between surveys. ALEC and EXPOsOMICS participants mainly differed by design in their smoking habits and asthma status, but their environmental exposure profiles were comparable (Table S2). Figure S2 shows the overall distributions of the aircraft, railway, and road traffic Lden and ${NO}_{2}$ and ${PM}_{2.5}$ exposures. The Spearman's rank correlations (*r*) of the five exposures are shown in Table S1. Correlation of ${NO}_{2}$ and ${PM}_{2.5}$ was 0.65. ${NO}_{2}$ had higher correlation with road traffic ($r = 0.41$) than railway ($r = 0.23$) and aircraft Lden ($r = 0.10$), whereas ${PM}_{2.5}$ had higher correlation with aircraft ($r = 0.23$) than railway ($r = 0.19$) and road traffic Lden ($r = 0.19$). Correlation patterns were consistent across SAP2 and SAP3.

###### 

Summary of the included SAPALDIA sample.

Table 1, in three columns, lists categories, SAPALDIA2 super a, and SAPALDIA3 super a.

                                                      SAPALDIA2[^*a*^](#TF2){ref-type="table-fn"}   SAPALDIA3[^*a*^](#TF2){ref-type="table-fn"}
  --------------------------------------------------- --------------------------------------------- ---------------------------------------------
  Categorical variables \[*n* (%)\]                   1,170 (100)                                   1,372 (100)
  Women                                               623 (53)                                      737 (54)
  Formal education (y)                                                                              
   $\leq 9$                                           56 (5)                                        62 (4)
   10--12                                             759 (65)                                      887 (65)
   $> 12$                                             355 (30)                                      423 (31)
  Smoking status                                                                                    
   Never                                              539 (46)                                      659 (48)
   Former                                             355 (30)                                      496 (36)
   Current                                            276 (24)                                      217 (16)
  Passive smoke exposure                              289 (25)                                      159 (12)
  Alcohol intake $> 1\text{ glass}/d$                 456 (39)                                      529 (38)
  Fruit intake $\leq 3\; d/{wk}$                      326 (28)                                      280 (20)
  Vegetable intake $\leq 3\; d/{wk}$                  86 (7)                                        100 (7)
  Urban area                                          689 (59)                                      897 (60)
  Prevalent asthma                                    161 (14)                                      398 (21)
  $\text{MVPA} < 150\text{ min}/{wk}$                 330 (28)                                      354 (26)
  Regular nighttime opening of windows                971 (83)                                      1,131 (82)
  Nested study                                                                                      
   ALEC                                               972 (83)                                      970 (71)
   EXPOsOMICS                                         198 (17)                                      402 (29)
  Continuous variables \[median (IQR)\]                                                             
   Age                                                50 (18)                                       58 (18)
   Body mass index (${kg}/m^{2}$)                     24.9 (5)                                      25.8 (6)
   Smoking pack-years                                 0.4 (15)                                      0 (14)
   Neighborhood index of socioeconomic position (%)   64.6 (13)                                     64.8 (13)
   Greenness index within 1-km buffer                 0.61 (0.2)                                    0.62 (0.2)
   Aircraft Lnight (dB)                               20 (2)                                        20.1 (5)
   Railway Lnight (dB)                                22.9 (14)                                     20 (10)
   Road traffic Lnight (dB)                           44.9 (111)                                    45.1 (11)
   Aircraft Lden (dB)                                 30 (9)                                        32.7 (8)
   Railway Lden (dB)                                  30 (11)                                       30 (7)
   Road traffic Lden (dB)                             53.7 (11)                                     53.9 (11)
   ${NO}_{2}$ ($\mu g/m^{3}$)                         20.2 (14)                                     16.7 (10)
   ${PM}_{2.5}$ ($\mu g/m^{3}$)                       14.3 (5)                                      12.9 (2)

Note: ALEC and EXPOsOMICS are European cohort consortia in which SAPALDIA participates. ALEC, Aging Lungs in European Cohorts; MVPA, moderate to vigorous physical activity; ${PM}_{2.5}$, particulate matter with aerodynamic diameter $< 2.5\;\mu m$; ${NO}_{2}$, nitrogen dioxide; SAPALDIA, Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults.

Population included in the analysis was limited to participants with complete methylome, exposure, and covariate data.

EWAS {#s3.1}
----

In the single exposure models (Table S3), we observed one genome-wide significant ($\text{FDR} = 0.040$) ${PM}_{2.5}$-associated CpG \[cg26704043 (*FARS2*)\] and one borderline-significant ($\text{FDR} = 0.077$) railway Lden-associated CpG \[cg25201280 (*ATPBD4*)\]. There were no genome-wide significant signals in the multiexposure model ([Table 2](#t2){ref-type="table"}). Here, the ${PM}_{2.5}$-associated cg26704043 (*FARS2*) got considerably weaker ($\text{FDR} = 0.180$), whereas the railway Lden-associated cg25201280 (*ATPBD4*) remained borderline-significant ($\text{FDR} = 0.075$). The top 10 CpGs of the single-exposure models were not entirely consistent with those of the multiexposure models, with varying degrees of overlap across exposures. However, overlapping CpGs were directionally consistent (for all exposures), and the top CpG was positionally consistent (except for road traffic Lden) between the single- and multiexposure models ([Tables 2](#t2){ref-type="table"} and S3).

###### 

Top ten CpGs independently associated with source-specific transportation noise and air pollution in the SAPALDIA study, multiexposure models.

Table 2 has 13 columns, namely, exposure, CpG I D, CHR, location, gene, feature, model 1 (beta), SE, p value, P (FDR), model 2 (beta), SE, and p value.

  Exposure                                       CpG ID                                         CHR         Location     Gene        Feature      Model 1     SE                       $p$-Value                P (FDR)      Model 2     SE                         $p$-Value
  ---------------------------------------------- ---------------------------------------------- ----------- ------------ ----------- ------------ ----------- ------------------------ ------------------------ ------------ ----------- -------------------------- ------------------------
  Aircraft Lden                                  cg02286155                                     5           176826262    NA          NA           $- 0.007$   0.001                    $1.48 \times 10^{- 6}$   0.637        $- 0.007$   0.001                      $2.13 \times 10^{- 6}$
  cg15063530                                     2                                              17716941    NA           NA          $- 0.009$    0.002       $8.14 \times 10^{- 6}$   0.659                    $- 0.009$    0.002       $8.14 \times 10^{- 6}$     
  cg16218477                                     7                                              1066167     *C7orf50*    Body        $- 0.004$    0.001       $8.53 \times 10^{- 6}$   0.659                    $- 0.004$    0.001       $7.05 \times 10^{- 6}$     
  cg21602842                                     18                                             46291908    *KIAA0427*   Body        $- 0.005$    0.001       $9.84 \times 10^{- 6}$   0.659                    $- 0.005$    0.001       $9.84 \times 10^{- 6}$     
  cg09042449                                     10                                             44064225    *ZNF239*     5′UTR       $- 0.002$    0.0004      $1.06 \times 10^{- 5}$   0.659                    $- 0.002$    0.0004      $1.18 \times 10^{- 5}$     
  cg10975000[^*a*^](#TF4){ref-type="table-fn"}   13                                             28371375    NA           NA          $- 0.002$    0.0005      $1.12 \times 10^{- 5}$   0.659                    $- 0.002$    0.0005      $1.16 \times 10^{- 5}$     
  cg06220958                                     17                                             10452851    *MYH2*       5′UTR       0.011        0.002       $1.24 \times 10^{- 5}$   0.659                    0.010        0.002       $1.43 \times 10^{- 5}$     
  cg25462190[^*a*^](#TF4){ref-type="table-fn"}   5                                              177547067   *N4BP3*      Body        $- 0.007$    0.002       $1.32 \times 10^{- 5}$   0.659                    $- 0.007$    0.002       $1.06 \times 10^{- 5}$     
  cg11944797                                     13                                             99135711    *STK24*      Body        $- 0.001$    0.0003      $1.38 \times 10^{- 5}$   0.659                    $- 0.001$    0.0003      $1.70 \times 10^{- 5}$     
  cg04635504                                     11                                             2829241     *KCNQ1*      Body        $- 0.005$    0.001       $1.61 \times 10^{- 5}$   0.664                    $- 0.005$    0.001       $1.62 \times 10^{- 5}$     
  Railway Lden                                   cg25201280[^*a*^](#TF4){ref-type="table-fn"}   15          35838552     *ATPBD4*    TSS200       $- 0.001$   0.0002                   $1.74 \times 10^{- 7}$   0.075        $- 0.001$   0.0002                     $1.99 \times 10^{- 7}$
  cg24653263[^*a*^](#TF4){ref-type="table-fn"}   5                                              38258335    *EGFLAM*     TSS200      $- 0.003$    0.001       $8.97 \times 10^{- 7}$   0.193                    $- 0.003$    0.001       $1.01 \times 10^{- 6}$     
  cg16825060[^*a*^](#TF4){ref-type="table-fn"}   8                                              144242342   *LY6H*       TSS1500     $- 0.003$    0.001       $2.34 \times 10^{- 6}$   0.256                    $- 0.003$    0.001       $2.56 \times 10^{- 6}$     
  cg23468045                                     5                                              12669584    NA           NA          0.001        0.0002      $2.37 \times 10^{- 6}$   0.256                    0.001        0.0002      $2.19 \times 10^{- 6}$     
  cg19270309[^*a*^](#TF4){ref-type="table-fn"}   17                                             77712853    *ENPP7*      3′UTR       0.002        0.0005      $3.25 \times 10^{- 6}$   0.266                    0.002        0.0005      $3.56 \times 10^{- 6}$     
  cg07461273                                     7                                              99697172    *MCM7*       Body        $- 0.004$    0.001       $3.78 \times 10^{- 6}$   0.266                    $- 0.004$    0.001       $3.70 \times 10^{- 6}$     
  cg01301319                                     7                                              27153580    *HOXA3*      5′UTR       $- 0.003$    0.001       $4.60 \times 10^{- 6}$   0.266                    $- 0.003$    0.001       $4.32 \times 10^{- 6}$     
  cg23113715[^*a*^](#TF4){ref-type="table-fn"}   22                                             25800663    NA           NA          $- 0.004$    0.001       $5.79 \times 10^{- 6}$   0.266                    $- 0.004$    0.001       $5.73 \times 10^{- 6}$     
  cg13402217                                     1                                              151584375   *SNX27*      TSS1500     $- 0.003$    0.001       $6.03 \times 10^{- 6}$   0.266                    $- 0.003$    0.001       $5.50 \times 10^{- 6}$     
  cg24047259[^*a*^](#TF4){ref-type="table-fn"}   14                                             65347275    NA           NA          $- 0.001$    0.0003      $7.35 \times 10^{- 6}$   0.266                    $- 0.001$    0.0003      $4.90 \times 10^{- 6}$     
  Road traffic Lden                              cg09129334                                     13          111837676    *ARHGEF7*   Body         $- 0.007$   0.001                    $1.73 \times 10^{- 6}$   0.384        $- 0.007$   0.001                      $2.12 \times 10^{- 6}$
  cg17383236[^*a*^](#TF4){ref-type="table-fn"}   7                                              100167504   NA           NA          $- 0.002$    0.0005      $2.76 \times 10^{- 6}$   0.384                    $- 0.002$    0.0005      $2.74 \times 10^{- 6}$     
  cg01066220                                     6                                              31696240    *DDAH2*      Body        0.001        0.0001      $3.48 \times 10^{- 6}$   0.384                    0.001        0.0001      $4.29 \times 10^{- 6}$     
  cg23910243[^*a*^](#TF4){ref-type="table-fn"}   16                                             31484618    *TGFB1I1*    Body        $- 0.002$    0.0005      $4.32 \times 10^{- 6}$   0.384                    $- 0.002$    0.0005      $7.13 \times 10^{- 6}$     
  cg06646021[^*a*^](#TF4){ref-type="table-fn"}   1                                              229406520   *RAB4A*      TSS1500     $- 0.005$    0.001       $4.47 \times 10^{- 6}$   0.384                    $- 0.005$    0.001       $4.78 \times 10^{- 6}$     
  cg03066594                                     20                                             10415919    *C20orf94*   TSS200      0.0005       0.0001      $6.00 \times 10^{- 6}$   0.386                    0.0004       0.0001      $7.82 \times 10^{- 6}$     
  cg03966094[^*a*^](#TF4){ref-type="table-fn"}   22                                             21058792    *TMEM191A*   Body        $- 0.003$    0.001       $7.06 \times 10^{- 6}$   0.386                    $- 0.003$    0.001       $6.73 \times 10^{- 6}$     
  cg13948857                                     5                                              131763756   *C5orf56*    Body        $- 0.003$    0.001       $7.17 \times 10^{- 6}$   0.386                    $- 0.003$    0.001       $7.22 \times 10^{- 6}$     
  cg08351004[^*a*^](#TF4){ref-type="table-fn"}   2                                              172965650   *DLX2*       Body        $- 0.002$    0.0005      $9.53 \times 10^{- 6}$   0.456                    $- 0.002$    0.0005      $1.23 \times 10^{- 5}$     
  cg13777730                                     1                                              234793300   NA           NA          $- 0.003$    0.001       $1.07 \times 10^{- 5}$   0.458                    $- 0.003$    0.001       $1.10 \times 10^{- 5}$     
  ${NO}_{2}$                                     cg04337651[^*a*^](#TF4){ref-type="table-fn"}   2           239344738    *ASB1*      Body         0.004       0.001                    $2.06 \times 10^{- 6}$   0.657        0.003       0.001                      $2.67 \times 10^{- 6}$
  cg18776472                                     10                                             50732819    *ERCC6*      Body        $- 0.001$    0.0002      $8.20 \times 10^{- 6}$   0.657                    $- 0.001$    0.0002      $1.00 \times 10^{- 5}$     
  cg18601596                                     6                                              39283313    *KCNK16*     Body        0.006        0.001       $8.21 \times 10^{- 6}$   0.657                    0.006        0.001       $8.62 \times 10^{- 6}$     
  cg12392998                                     17                                             79550668    *NPLOC4*     Body        $- 0.002$    0.0004      $8.72 \times 10^{- 6}$   0.657                    $- 0.002$    0.0004      $1.04 \times 10^{- 5}$     
  cg16550606                                     13                                             50160670    *RCBTB1*     TSS1500     0.004        0.001       $1.33 \times 10^{- 5}$   0.657                    0.004        0.001       $1.44 \times 10^{- 5}$     
  cg25266109                                     19                                             12404608    *ZNF44*      Body        $- 0.0004$   0.0001      $1.38 \times 10^{- 5}$   0.657                    $- 0.0004$   0.0001      $1.20 \times 10^{- 5}$     
  cg01746514[^*a*^](#TF4){ref-type="table-fn"}   14                                             24520922    *LRRC16B*    TSS1500     $- 0.001$    0.0002      $1.43 \times 10^{- 5}$   0.657                    $- 0.001$    0.0002      $1.58 \times 10^{- 5}$     
  cg15811902                                     15                                             75918385    *SNUPN*      5′UTR       $- 0.002$    0.0005      $1.61 \times 10^{- 5}$   0.657                    $- 0.002$    0.0005      $1.48 \times 10^{- 5}$     
  cg26898336[^*a*^](#TF4){ref-type="table-fn"}   17                                             15244519    *TEKT3*      5′UTR       0.002        0.0005      $1.65 \times 10^{- 5}$   0.657                    0.002        0.0005      $1.89 \times 10^{- 5}$     
  cg21099332                                     5                                              39270715    NA           NA          0.004        0.001       $1.66 \times 10^{- 5}$   0.657                    0.004        0.001       $1.88 \times 10^{- 5}$     
  ${PM}_{2.5}$                                   cg26704043                                     6           5282702      *FARS2*     5′UTR        0.014       0.003                    $4.18 \times 10^{- 7}$   0.180        0.014       0.003                      $6.22 \times 10^{- 7}$
  cg05157625                                     14                                             93153553    *RIN3*       Body        0.021        0.004       $1.08 \times 10^{- 6}$   0.231                    0.021        0.004       ${1.13 \times 10}^{- 6}$   
  cg20099458[^*a*^](#TF4){ref-type="table-fn"}   7                                              5272275     *WIPI2*      3′UTR       0.014        0.003       $1.61 \times 10^{- 6}$   0.231                    0.014        0.003       $1.58 \times 10^{- 6}$     
  cg06587257                                     12                                             50452135    *ACCN2*      5′UTR       0.022        0.005       $2.71 \times 10^{- 6}$   0.292                    0.023        0.005       $2.04 \times 10^{- 6}$     
  cg14531665                                     9                                              91058614    *SPIN1*      Body        0.012        0.003       $5.91 \times 10^{- 6}$   0.398                    0.011        0.003       $7.07 \times 10^{- 6}$     
  cg06526020                                     6                                              34308880    *NUDT3*      Body        0.029        0.006       $6.43 \times 10^{- 6}$   0.398                    0.028        0.006       $8.80 \times 10^{- 6}$     
  cg21058520                                     6                                              100914733   NA           NA          0.004        0.001       $6.76 \times 10^{- 6}$   0.398                    0.004        0.001       $8.31 \times 10^{- 6}$     
  cg16259904                                     10                                             134146220   *LRRC27*     5′UTR       0.027        0.006       $8.90 \times 10^{- 6}$   0.398                    0.027        0.006       $1.01 \times 10^{- 5}$     
  cg12770741                                     17                                             883776      *NXN*        TSS1500     0.018        0.004       $9.15 \times 10^{- 6}$   0.398                    0.018        0.004       $1.01 \times 10^{- 5}$     
  cg26750893[^*a*^](#TF4){ref-type="table-fn"}   2                                              38043481    NA           NA          0.016        0.004       $1.05 \times 10^{- 5}$   0.398                    0.016        0.004       $1.28 \times 10^{- 5}$     

Note: Beta coefficients represent increase or decrease in DNA methylation per $10{\, dB}$ increase in aircraft, railway or road traffic Lden or 10 $\mu g/m^{3}$ increase in ${NO}_{2}$ or ${PM}_{2.5}$. All estimates were from multiexposure epigenome-wide linear mixed-effects models, with random intercept at the level of participant. Multiexposure models included all five exposures (aircraft, railway, road traffic Lden and respective truncation indicators, ${NO}_{2}$ and ${PM}_{2.5}$) at the same time. In a preliminary step, DNA methylation $\beta$-values were regressed on the Illumina control probe-derived first 30 principal components to correct for correlation structures and technical bias, and residuals of these regressions covering 430,477 CpGs were used as the technical bias-corrected methylation level at the CpG sites. Extreme values of the residuals (lying beyond three times the interquartile range below the first quartile and above the third quartile at each CpG site) were replaced with their corresponding detection threshold value ("modified winsorization"). The "winsorized" data were then used as the dependent variables in the EWAS. Model 1: adjusted for age; sex; educational level; area; neighborhood socioeconomic status; greenness index; smoking status; smoking pack-years; exposure to passive smoke; consumption of fruits, vegetables and alcohol; nested study; asthma status; noise truncation indicators; survey; and leukocyte composition (main model). Model 2: Model $1 + \text{body}$ mass index and physical activity. CHR, chromosome; CpG, Cytosine-phosphate-Guanine; Lden, day-evening-night noise level; NA, not annotated; ${NO}_{2}$, particulate matter with aerodynamic diameter $< 2.5\;\mu m$; SAPALDIA, Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults; SE, standard error.

Location overlaps with significant differentially methylated region.

In the multiexposure model, aircraft Lden (cg02286155), railway Lden \[cg25201280 (*ATPBD4*)\] and road traffic Lden cg09129334 (*ARHGEF7*) were associated with reduced methylation, whereas ${NO}_{2}$ \[cg04337651 (*ASB1*)\] and ${PM}_{2.5}$ \[cg26704043 (*FARS2*)\] were associated with increased methylation, at their respective top CpG sites. Among the top 10 signals, we observed decreased methylation at 9 (90%), 8 (80%), and 8 (80%) CpGs in relation to aircraft, railway, and road traffic Lden, respectively, and increased methylation at 5 (50%) and 10 (100%) CpGs in relation to ${NO}_{2}$ and ${PM}_{2.5}$, respectively. These CpGs were generally robust to adjustment for BMI and physical activity ([Table 2](#t2){ref-type="table"}) and showed consistent effect direction when stratified by nested study (Table S4). Associations were also robust in the model limited to participants reporting regular nighttime window opening (Table S5). The "nonwinsorized" model highlighted few CpGs where extreme values would potentially bias their estimates if unaddressed. These included directionally consistent but considerably weaker effects on aircraft Lden-associated cg11944797 (*STK24*) and cg10975000; road traffic Lden-associated cg08351004 (*DLX2*); ${NO}_{2}$-associated cg18776472 (*ERCC6*), cg12392998 (*NPLOC2*), and cg26898336 (*TEKT3*); and a stronger and genome-wide significant effect on ${PM}_{2.5}$-associated cg21058520 (Table S6). Results from the multiexposure main model of CpGs associated with aircraft, railway, and road traffic Lden, ${NO}_{2}$---at nominal $p\text{-value} < 1.00 \times 10^{- 3}$---are presented in Tables S2--S6.

Post hoc analysis of overlap among the top 100 exposure-specific CpGs identified from the multiexposure EWAS showed minimal signal overlap between exposures ([Figure 2A](#f2){ref-type="fig"}). We identified two overlapping signals between road traffic Lden and ${NO}_{2}$ \[cg12439232 and cg15590912 (*CCSAP*)\]. Yet, road traffic Lden was associated with decreased methylation, whereas ${NO}_{2}$ was associated with increased methylation at both sites (Tables S4 and S5). Complete EWAS results from the single- and multiexposure main models of 430,477 CpGs in relation to aircraft, railway, and road traffic Lden; ${NO}_{2}$; and ${PM}_{2.5}$ have been deposited in the Zenodo public online depository (<https://zenodo.org/record/3832253#.XsLLJEKxU2x>).

![Overlap of top 100 CpG signals (A) and genes annotated to significant differentially methylated regions (B) in relation to aircraft, railway, and road traffic Lden, ${NO}_{2}$, and ${PM}_{2.5}$ identified from multiexposure EWAS in the SAPALDIA study. Note: EWAS, epigenome-wide association study; Lden, day-evening-night noise level; ${NO}_{2}$, nitrogen dioxide; ${PM}_{2.5}$, particulate matter $< 2.5\text{ microns}$ in diameter; SAPALDIA, Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults. CpGs were identified by multiexposure EWAS using multivariable linear mixed-effects models with random intercepts at the level of participants, and adjusted for age, sex, educational level, area, neighborhood socioeconomic status, greenness index, smoking status, smoking pack-years, exposure to passive smoke, consumption of fruits, vegetables and alcohol, nested study, asthma status, noise truncation indicators, survey and leukocyte composition. In a preliminary step, DNA methylation $\beta$-values were regressed on the Illumina control probe-derived first 30 principal components to correct for correlation structures and technical bias, and residuals of these regressions covering 430,477 CpGs were used as the technical bias-corrected methylation level at the CpG sites. Extreme values of the residuals (lying beyond three times the interquartile range below the first quartile and above the third quartile at each CpG site) were replaced with their corresponding detection threshold value ("modified winsorization"). The "winsorized" data were then used as the dependent variables in the present EWAS. CpGs (annotated gene) intersecting at the level of road traffic Lden and ${NO}_{2}$ were cg12439232 and cg15590912 (*CCSAP*). Genes (DMR) intersecting at the level of road traffic Lden and ${PM}_{2.5}$ was *PRRT1* (chr6:32,115,964--32,117,401); and at the level of aircraft and road traffic Lden and ${PM}_{2.5}$ was *HOXA2* (chr7:27,141,774--27,143,806). *VTRNA2-1* (chr5:135,415,129--135,416,613) intersected between aircraft and railway Lden, *ZFP57* (chr6:29,648,161--29,649,084), between railway Lden and ${NO}_{2}$, and *ZSCAN31* (chr6:28,303,923--28,304,451), between road traffic Lden and ${NO}_{2}$. *TRIM39*, *TRIM39-RPP21*, and *HCG18* (chr6:30,296,689--30,297,941) intersected between railway Lden and ${PM}_{2.5}$, whereas *SLC27A3* (chr1:153,746,588--153,747,856), *B3GALT4* (chr6:33,244,976--33,246,185), *EN2*, and *AC008060.8* (chr7:155,249,398--155,251,925) intersected between railway and road traffic Lden.](ehp6174_f2){#f2}

We identified independent DMRs ($\text{FDR} = 0.05$) across all exposures in the main model ([Table 3](#t3){ref-type="table"}). There were 14 (10), 48 (39), 183 (189), 8 (8), and 71 (60) DMRs (genes), associated with aircraft, railway, and road traffic Lden, ${NO}_{2}$, and ${PM}_{2.5}$, respectively. Among the top 10 CpGs identified in the multiexposure model, two aircraft \[cg10975000 and cg25462190 (*N4BP3*)\], six railway \[cg25201280 (*ATPBD4*), cg24653263 (EGFLAM), cg16825060 (*LY6H*), cg19270309 (*ENPP7*), cg23113715, and cg24047259\], and five road traffic Lden-associated CpGs \[cg17383236, cg23910243 (*TGFB1I1*), cg06646021 (*RAB4A*), cg03966094 (*TMEM191A*), and cg08351004 (*DLX2*)\] were within the exposure-specific DMRs. Three ${NO}_{2}$ \[cg04337651 (*ASB1*), cg01746514 (*LRRC16B*) and cg26898336 (*TEKT3*)\] and two ${PM}_{2.5}$-associated CpGs \[cg20099458 (*WIPI2*) and cg26750893\] were also within the exposure-specific DMRs. Top DMRs independently associated with exposures, were annotated to *VTRNA2-1* (aircraft and railway Lden; Chr5:135,415,129--135,416,613), *OXT* (road traffic Lden; Chr20:3,051,954--3,053,196), *ZSCAN31* (${NO}_{2}$; Chr6:28,303,923--28,304,451), and *TRIM39, HCG18,* and *TRIM39-RPP21* (${PM}_{2.5}$; Chr6:30,296,689--30,297,941). Most of the CpGs within the DMRs associated with source-specific Lden showed decreased methylation ($\text{aircraft} = 64\%$, $\text{railway} = 69\%$, and $\text{road\ traffic} = 93\%$), whereas those associated with air pollution showed increased methylation (${NO}_{2} = 63\%$ and ${PM}_{2.5} = 93\%$). Tables S7 and S8 show the results from the multiexposure main model of DMRs associated with aircraft, railway, and road traffic Lden; ${NO}_{2}$; and ${PM}_{2.5}$ at $\text{FDR} < \, 0.05$.

###### 

Summary of EWAS-derived differentially methylated regions and enrichment in relation to transportation noise and air pollution exposure in the SAPALDIA study.

Table 3 has 9 columns, namely, exposure, DMRs (genes), n, average effect on DMRs, Top DMR (gene), CpGs in top DMR, n, FDR p value, top DMR, Top enriched canonical pathway (T E CP), genes in T E CP, and top enriched disease networks.

  Exposure            DMRs \[Genes (*n*)\]   Average effect on DMRs           Top DMR (Gene)                                            CpGs in top DMR (*n*)   FDR $p$-value (top DMR)   Top enriched canonical pathway (TECP)                                                              Genes in TECP                                              Top enriched disease networks
  ------------------- ---------------------- -------------------------------- --------------------------------------------------------- ----------------------- ------------------------- -------------------------------------------------------------------------------------------------- ---------------------------------------------------------- -------------------------------------------------------------------------------------------
  Aircraft Lden       14 (10)                $\downarrow$ methylation (64%)   Chr5:135415129--135416613 (*VTRNA2-1*)                    19                      $8.04 \times 10^{- 14}$   NA                                                                                                 NA                                                         Cell cycle, embryonic development, organismal development
  Railway Lden        48 (39)                $\downarrow$ methylation (69%)   Chr5:135415129--135416613 (*VTRNA2-1*)                    19                      $3.61 \times 10^{- 5}$    Type II diabetes mellitus signaling; diphthamide biosynthesis                                      *PRKAA1, SLC27A3, TNFRSF11B, DPH6*                         cardiovascular system development and function, gene expression, organ development
  Road traffic Lden   183 (189)              $\downarrow$ methylation (93%)   Chr20:3051954--3053196 (*OXT*)                            13                      $3.93 \times 10^{- 6}$    Wnt/$\beta\text{-catenin}$ signaling; cholecystokinin/gastrin-mediated signaling                   *CDH1, CSNK1E, SOX2, SOX8, WNT16, MEF2D, PXN, SHC1, TNF*   Cell-mediated immune response, cell-to-cell signaling and interaction, cellular movement
  ${NO}_{2}$          8 (8)                  $\uparrow$ methylation (63%)     Chr6:28303923--28304451 (*ZSCAN31*)                       11                      $2.57 \times 10^{- 6}$    NA                                                                                                 NA                                                         Cell cycle, cell-to-cell signaling and interaction, post-translational modification
  ${PM}_{2.5}$        71 (60)                $\uparrow$ methylation (93%)     Chr6:30296689--30297941 (*TRIM39, HCG18, TRIM39-RPP21*)   14                      $4.28 \times 10^{- 8}$    $\beta\text{-alanine}$ and 4-aminobutyrate degradation I; systemic lupus erythematosus signaling   *ABAT1, PRPF31, PRPF8, PTPN6*                              Cell cycle, nervous system development and function, organismal injury, and abnormalities

Note: Each DMR analysis had the corresponding multiexposure EWAS-derived parameters as input. Multiexposure EWAS derived from linear mixed-effects models, with random intercept at the level of participant, and adjusted for age; sex; educational level; area; neighborhood socioeconomic status; greenness index; smoking status; smoking pack-years; exposure to passive smoke; consumption of fruits, vegetables, and alcohol; nested study; asthma status; survey; noise truncation indicators; and leukocyte composition. In a preliminary step, DNA methylation $\beta$-values were regressed on the Illumina control probe-derived first 30 principal components to correct for correlation structures and technical bias, and residuals of these regressions covering 430,477 CpGs were used as the technical bias-corrected methylation level at the CpG sites. Extreme values of the residuals (lying beyond three times the interquartile range below the first quartile and above the third quartile at each CpG site) were replaced with their corresponding detection threshold value ("modified winsorization"). The "winsorized" data were then used as the dependent variables in the EWAS. Significant ($\text{FDR} < \, 0.05$) and annotated DMRs were used for canonical pathway and network enrichment in the Ingenuity Pathway Analysis software (Ingenuity Systems). ↓, decrease in methylation; ↑, increase in methylation; CpG, Cytosine-phosphate-Guanine; DMRs, limiting statistical power to detect enriched canonical pathways; EWAS, epigenome-wide association study; FDR, false discovery rate; Lden, day-evening-night noise level; NA, not applicable due to few significant and annotated; ${NO}_{2}$, nitrogen dioxide; ${PM}_{2.5}$, particulate matter with aerodynamic diameter $< 2.5\;\mu m$; SAPALDIA, Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults.

Post hoc analysis of overlap among the gene-annotated significant DMRs also showed minimal overlap between exposures ([Figure 2B](#f2){ref-type="fig"}). *SLC27A3*, *B3GALT4*, *EN2*, and *AC008060.8* overlapped between railway and road traffic Lden; *TRIM39*, *TRIM39-RPP21*, and *HCG18* overlapped between railway Lden and ${PM}_{2.5}$; and *HOXA2* overlapped between aircraft and road traffic Lden and ${PM}_{2.5}$. Other overlapping genes include *VTRNA2-1* (aircraft and railway Lden), *ZFP57* (railway Lden and ${NO}_{2}$), and *ZSCAN31* (road traffic Lden and ${NO}_{2}$), and *PRRT1* (road traffic Lden and ${PM}_{2.5}$). Overlapping DMRs showed opposing effect direction between exposures, except for consistently increased methylation at *TRIM39*, *TRIM39-RPP21*, *HCG18* (railway Lden and ${PM}_{2.5}$), and *HOXA2* (aircraft Lden and ${PM}_{2.5}$), and decreased methylation at *SLC27A3*, *B3GALT4*, *EN2*, and *AC008060.8* (railway and road traffic Lden) (Tables S7 and S8).

Pathway Enrichment {#s3.2}
------------------

For the candidate single phenotype and combined "allostatic load" pathways, multiple testing-corrected enrichment analyses showed varying enrichment across exposures ([Table 4](#t4){ref-type="table"}). Considering the results for single phenotypes, ${PM}_{2.5}$-related methylation was the most enriched, whereas ${NO}_{2}$-related methylation was the least enriched. Single pathways ($p$-values) enriched for ${PM}_{2.5}$ included CRP (0.0004), glycemia (0.0947), WC (0.0004), BMI (0.0004), and eGFR (0.0004). Aircraft and road traffic Lden-related methylation were enriched for CRP (0.0038; 0.0395), BMI (0.0007; 0.0008), and eGFR (0.0015; 0.0031). Railway Lden-related methylation was enriched for eGFR (0.0562) and CAR (0.0229), whereas ${NO}_{2}$-related methylation was enriched only for eGFR (0.0058). Considering the global "allostatic load" pathway, we found consistent enrichment across all exposures, including aircraft (0.0004), railway (0.0871), and road traffic Lden (0.0004); ${PM}_{2.5}$ (0.0004); and ${NO}_{2}$ (0.0510).

###### 

Pathway enrichment tests ($p$-values) for transportation noise and air pollution exposures based on curated CpGs reported for selected cross-systemic outcomes.

Table 4 has 12 columns, namely, exposure, CRP, metabolic syndrome, lipids, FG per HbA1c, insulin, WC, BMI, blood pressure, e GFR, C A R, and Allostatic load.

  Exposure            CRP      Metabolic syndrome   Lipids   FG/HbA1c   Insulin   WC       BMI      Blood pressure   eGFR     CAR      Allostatic load
  ------------------- -------- -------------------- -------- ---------- --------- -------- -------- ---------------- -------- -------- -----------------
  N (CpGs)            256      10                   14       9          158       168      893      20               296      7        1,626
  Aircraft Lden       0.0038   0.5915               0.6326   0.4545     0.6630    0.2925   0.0007   0.1020           0.0015   0.9096   0.0004
  Railway Lden        0.3163   0.4943               0.9533   0.5778     0.6284    0.3001   0.9023   0.6773           0.0562   0.0229   0.0871
  Road traffic Lden   0.0395   0.2434               0.9969   0.3879     0.3461    0.5361   0.0008   0.2858           0.0031   0.8013   0.0004
  ${NO}_{2}$          0.2117   0.1237               0.7831   0.5733     0.3697    0.6873   0.8818   0.5355           0.0058   0.9728   0.0510
  ${PM}_{2.5}$        0.0004   0.4517               0.1263   0.0947     0.3451    0.0004   0.0004   0.3759           0.0004   0.3814   0.0004

Note: Lipids includes triglycerides, high-, low- and very low-density lipoprotein cholesterol. Insulin includes measures of insulin secretion and resistance. WC also includes central obesity and adiposity. BMI also includes general obesity. Blood pressure includes systolic and diastolic blood pressure. eGFR also includes impaired renal function. CAR includes acceleration and deceleration capacity. Allostatic load combines all the phenotypes. Pathway enrichment $p$-values derived from Weighted Kolmogorov-Smirnov method using the absolute values of test statistics from multiexposure epigenome-wide association studies (EWAS), and comparing the EWAS-derived CpGs mapped to each pathway to the empirical null distribution derived by 10,000 permutation samples. The overall procedure included permutation-based multiple testing correction. EWAS was done using linear mixed-effects models, with random intercept at the level of participant, and adjusted for age; sex; educational level; area; neighborhood socioeconomic status; greenness index; smoking status; smoking pack-years; exposure to passive smoke; consumption of fruits, vegetables, and alcohol; nested study; asthma status; noise truncation indicators; survey; and leukocyte composition. In a preliminary step, DNA methylation $\beta$-values were regressed on the Illumina control probe-derived first 30 principal components to correct for correlation structures and technical bias, and residuals of these regressions covering 430,477 CpGs were used as the technical bias-corrected methylation level at the CpG sites. Extreme values of the residuals (lying beyond three times the interquartile range below the first quartile and above the third quartile at each CpG site) were replaced with their corresponding detection threshold value ("modified winsorization"). The "winsorized" data were then used as the dependent variables in the EWAS. BMI, body mass index; CAR, cardiac autonomic response; CpG, Cytosine-phosphate-Guanine; CRP, C-reactive proteins; eGFR, estimated glomerular filtration rate; FG, fasting glucose; HbA1c, glycated hemoglobin; Lden, day-evening-night noise level; ${NO}_{2}$, nitrogen dioxide; ${PM}_{2.5}$, particulate matter $< 2.5\text{ microns}$ in diameter; WC, waist circumference.

Agnostic functional enrichment showed significantly enriched canonical pathways for railway, road traffic Lden and ${PM}_{2.5}$, with predominance of inflammatory and immune regulation-related pathways across exposures (Table S9). Some of the enriched canonical pathways included type 2 diabetes signaling, tight junction signaling, mTOR signaling, and lipopolysaccharide/interleukin-1 (IL-1)--mediated inhibition of retinoid X receptor (RXR) function (railway Lden); Wnt/$\beta\text{-catenin}$ signaling, cholecystokinin/gastrin-mediated signaling, G-protein coupled receptor signaling, and Th1 and Th2 activation pathways (road traffic Lden); $\beta\text{-alanine}$, 4-aminobutyrate degradation; and systematic lupus erythematosus signaling, and IL-4 signaling (${PM}_{2.5}$). Network analyses showed the enrichment for disease mechanisms related to cellular signaling/interaction and embryonic/organ development (all exposures), cell-mediated immune/inflammatory responses (road traffic Lden and ${PM}_{2.5}$) and diseases related to connective tissue development and function (railway and road traffic Lden). Pathways related to cardiovascular function, gene expression, and respiratory system disease (railway Lden); carbohydrate and small molecule transport/biochemistry, cancer, and auditory function (road traffic Lden); and hematological and nervous system function (${PM}_{2.5}$) were enriched (Table S10).

### Replication of previously reported ${NO}_{2}$ and ${PM}_{2.5}$--associated CpGs. {#s3.2.1}

Using the single-exposure model, corresponding to the previous EWAS studies, we replicated the increased methylation in cg08500171 (*BAT2*) associated with ${NO}_{2}$ ($p = 0.042$). This replication remained robust in the multiexposure model ($p = 0.019$). We observed a borderline significant decreased methylation in cg17629796 associated with ${PM}_{2.5}$ ($p = 0.076$) in the single-exposure model, which became statistically significant in the multiexposure model ($p = 0.033$). Nine (41%) ${NO}_{2}$-associated CpGs and 5 (50%) ${PM}_{2.5}$-associated CpGs had the same direction of effect in the SAPALDIA study ([Table 5](#t5){ref-type="table"}).

###### 

Replication of previously reported EWAS signals for long-term exposure to ${NO}_{2}$ and ${PM}_{2.5}$, in the SAPALDIA study, single- and multiexposure models.

Table 5 has 14 columns, namely, air pollutant; cohort (reference), CpG I D, CHR, location, gene, beta, SE, p value, SAPALDIA (single exposure model; beta), SE, p value, SAPALDIA (multiexposure model; beta), SE, and p value.

  Air pollutant; Cohort (Reference)                                               CpG ID       CHR         Location       Gene                Beta          SE                        $p$-Value                SAPALDIA (single-exposure model)   SE       $p$-Value     SAPALDIA (multiexposure model)   SE       $p$-Value
  ------------------------------------------------------------------------------- ------------ ----------- -------------- ------------------- ------------- ------------------------- ------------------------ ---------------------------------- -------- ------------- -------------------------------- -------- -----------
  ${NO}_{2}$; LifeLines, [@c28]                                                   cg04908668   6           32823941       *PSMB9*             $- 0.012$     0.002                     $7.94 \times 10^{- 9}$   0.0003                             0.0003   0.333         0.0004                           0.0004   0.322
  cg14938677                                                                      7            127231698   *ARF5*         0.023               0.004         $1.05 \times 10^{- 8}$    0.0004                   0.001                              0.619    0.0004        0.001                            0.663    
  cg00344801                                                                      22           46685728    *TTC38*        $- 0.028$           0.005         $2.38 \times 10^{- 8}$    0.001                    0.001                              0.209    0.001         0.001                            0.282    
  cg18379295                                                                      14           52326155    *GNG2*         0.020               0.004         $3.50 \times 10^{- 8}$    $- 0.001$                0.001                              0.204    $- 0.001$     0.001                            0.367    
  cg25769469                                                                      5            71643841    *PTCD2*        0.035               0.006         $3.69 \times 10^{- 8}$    0.001                    0.002                              0.547    0.002         0.002                            0.237    
  cg02234653                                                                      2            224625080   *AP1S3*        $- 0.017$           0.003         $4.70 \times 10^{- 8}$    0.0005                   0.001                              0.553    0.0003        0.001                            0.752    
  cg08500171[^*a*^](#TF8){ref-type="table-fn"}                                    6            31590674    *BAT2*         0.024               0.004         $9.81 \times 10^{- 8}$    0.002                    0.001                              0.042    0.003         0.001                            0.019    
  ${NO}_{2}$; EPIC-ITALY, [@c93]                                                  cg08120023   1           116947203      *C1orf203*          $- 0.003$     0.0005                                             0.001                              0.001    0.586         0.002                            0.001    0.179
  cg22856765                                                                      8            42693384    *THAP1*        $- 0.008$           0.001         $4.27 \times 10^{- 9}$    $- 0.00001$              0.0002                             0.960    $- 0.00001$   0.0002                           0.930    
  cg18164357                                                                      11           77534497    *C11orf67*     $- 0.009$           0.001         $9.61 \times 10^{- 9}$    0.0005                   0.0003                             0.042    0.001         0.0003                           0.016    
  cg13918628                                                                      9            35610380    *CD72*         $- 0.012$           0.002         $1.02 \times 10^{- 8}$    $- 0.0003$               0.0002                             0.184    $- 0.0005$    0.0003                           0.074    
  cg03870188                                                                      13           113717830   *MCF2L*        $- 0.004$           0.001         $1.02 \times 10^{- 8}$    0.0001                   0.0003                             0.670    0.0001        0.0003                           0.650    
  cg20939320                                                                      3            132563279   *NCRNA00119*   $- 0.006$           0.001         $3.49 \times 10^{- 8}$    0.001                    0.001                              0.091    0.001         0.001                            0.185    
  cg13420207                                                                      7            81666278    *CACNA2D1*     $\begin{array}{l}   0.002         $5.56 \times 10^{- 8}$    $- 0.00004$              0.001                              0.947    $- 0.00003$   0.001                            0.973    
                                                                                                                          {- 0.010} \\                                                                                                                                                                             
                                                                                                                          \end{array}$                                                                                                                                                                             
  cg04914283                                                                      1            23181832    *EPHB2*        $- 0.005$           0.001         $5.85 \times 10^{- 8}$    0.001                    0.001                              0.298    0.001         0.001                            0.118    
  cg21156210                                                                      4            100485208   *RG9MTD2*      0.010               0.002         $6.03 \times 10^{- 8}$    $- 0.00002$              0.0002                             0.941    0.0001        0.0003                           0.731    
  cg16205861                                                                      12           54146572    NA             $- 0.004$           0.001         $6.57 \times 10^{- 8}$    $- 0.0001$               0.0005                             0.788    $- 0.0001$    0.0005                           0.882    
  cg12790758                                                                      15           37369914    *MEIS2*        $- 0.004$           0.001         $7.06 \times 10^{- 8}$    0.0006                   0.0005                             0.287    $- 0.0001$    0.001                            0.898    
  cg18201392                                                                      1            185023741   *RNF2*         $\begin{array}{l}   0.001         $8.02 \times 10^{- 8}$    0.0002                   0.0001                             0.118    0.0002        0.0001                           0.133    
                                                                                                                          {- 0.005} \\                                                                                                                                                                             
                                                                                                                          \end{array}$                                                                                                                                                                             
  ${NO}_{2}$; Korean COPD Cohort, [@c68]                                          cg05171937   12          27396765       *STK38L*            0.010         0.002                     $1.10 \times 10^{- 8}$   0.003                              0.001    0.068         0.002                            0.002    0.125
  cg06226567                                                                      20           22559676    *C20orf56*     0.003               0.001         $3.50 \times 10^{- 8}$    0.00002                  0.0001                             0.863    0.0001        0.0002                           0.514    
  cg26583725                                                                      13           110397643   NA             $- 0.001$           $2.3^{- 4}$   $4.90 \times 10^{- 8}$    0.0001                   0.0001                             0.183    0.0001        0.0001                           0.228    
  ${PM}_{2.5}$; EPIC-ITALY, [@c93]                                                cg23890774   19          36618841       NA                  0.078         0.014                     $1.98 \times 10^{- 8}$   0.0001                             0.0003   0.704         0.0003                           0.0003   0.263
  ${PM}_{2.5}$; EPIC-NL never-smokers, [@c93][^*b*^](#TF9){ref-type="table-fn"}   cg12575202   10          133331128      NA                  $- 0.467$     0.080                     $5.40 \times 10^{- 9}$   $- 0.001$                          0.003    0.786         $- 0.002$                        0.003    0.529
  cg08630381                                                                      13           100612277   NA             0.461               0.073         $2.58 \times 10^{- 10}$   $- 0.001$                0.001                              0.415    $- 0.001$     0.001                            0.394    
  cg17629796[^*a*^](#TF8){ref-type="table-fn"}                                    13           30707265    NA             $- 0.563$           0.094         $2.11 \times 10^{- 8}$    $- 0.002$                0.001                              0.076    $- 0.003$     0.001                            0.033    
  cg07084345                                                                      15           61972967    NA             $- 0.512$           0.075         $7.26 \times 10^{- 12}$   0.002                    0.008                              0.816    0.002         0.008                            0.769    
  cg04319606                                                                      2            26785290    *C2orf70*      0.261               0.068         $1.31 \times 10^{- 7}$    0.0002                   0.002                              0.893    $- 0.00002$   0.002                            0.989    
  cg09568355                                                                      2            45228633    NA             0.261               0.049         $1.41 \times 10^{- 7}$    0.003                    0.002                              0.286    0.004         0.003                            0.179    
  cg03513315                                                                      2            30988383    *PES1*         0.307               0.058         $1.35 \times 10^{- 7}$    $- 0.0003$               0.001                              0.631    $- 0.0001$    0.001                            0.837    
  cg25489413                                                                      7            44794343    *ZMIZ2*        $- 0.365$           0.068         $6.48 \times 10^{- 8}$    0.001                    0.002                              0.712    0.0002        0.002                            0.933    
  cg00005622                                                                      8            145180403   NA             $- 0.398$           0.064         $5.16 \times 10^{- 10}$   $- 0.004$                0.001                              0.109    $- 0.004$     0.003                            0.136    

Note: Beta coefficients represent increase or decrease in DNA methylation in relation to ${NO}_{2}$ or ${PM}_{2.5}$ exposure. In a preliminary step, DNA methylation $\beta$-values were regressed on the Illumina control probe-derived first 30 principal components to correct for correlation structures and technical bias, and residuals of these regressions covering 430,477 CpGs were used as the technical bias-corrected methylation level at the CpG sites. Extreme values of the residuals (lying beyond three times the interquartile range below the first quartile and above the third quartile at each CpG site) were replaced with their corresponding detection threshold value ("modified winsorization"). The "winsorized" data were then used as the dependent variables in the present EWAS. The multiexposure model contained all five exposures at same time. All SAPALDIA estimates were derived from linear mixed-effects EWAS models, with random intercept at the level of participant, adjusted for age; sex; educational level; area; neighborhood socioeconomic status; greenness index; smoking status; smoking pack-years; exposure to passive smoke; consumption of fruits, vegetables, and alcohol; nested study; asthma status; noise truncation indicators; survey; and leukocyte composition. Multiexposure model included all five exposures (Aircraft, railway, road traffic Lden and respective truncation indicators, ${NO}_{2}$ and ${PM}_{2.5}$) at the same time. CHR, chromosome; COPD, chronic obstructive pulmonary disease; CpG, Cytosine-phosphate-Guanine; EPIC, European Prospective Investigation into Cancer and Nutrition; EWAS, epigenome-wide association study; N.A*.,* not annotated; NL, Netherlands; ${NO}_{2}$, nitrogen dioxide; ${PM}_{2.5}$, particulate matter with aerodynamic diameter $< 2.5\;\mu m$; SAPALDIA, Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults; SE, standard error.

Validated in the SAPALDIA study.

SAPALDIA estimates derived from never-smoker sample comparable to the EPIC-NL never-smoker estimates.

Discussion {#s4}
==========

In this first multiexposure EWAS covering long-term aircraft, railway, and road traffic noise, as well as ${NO}_{2}$ and ${PM}_{2.5}$ exposures, we found genome-wide significant signals---at the level of genomic regions---associated with source-specific transportation noise and air pollution exposures. We demonstrated some mutual confounding of the associations of exposures with DNA methylation, where single exposure models slightly overestimated the observed methylation effect. Overall, methylation signals minimally overlapped but showed common enrichment of inflammation and immune response-related pathways across exposures. In this study, we also validated air pollution--related CpG signals identified in external EWAS.

The railway noise--related decrease in methylation at cg25201280 (transcription start site 200 of *ATPBD4* gene on chromosome 15) and ${PM}_{2.5}$-related increase in methylation at cg26704043 (5′ untranslated region of *FARS2* gene on chromosome 6) were the strongest single CpG signals identified in the study. *ATPBD4* (or *DPH6*) is a protein-coding gene that regulates adenosine triphosphate (ATP) binding and diphthamide synthase activity, within the protein metabolism pathway ([@c23]; [@c123]). Polymorphisms in this gene were associated---in various genome-wide association studies (GWAS)---with adiposity ([@c65]; [@c94]), cognitive function ([@c67]; [@c70]), and Crohn's disease progression ([@c88]). *FARS2* is a protein-coding gene that regulates the translation of mitochondrial proteins and gene expression ([@c16]). Variants of this gene were associated---in GWAS---with extreme obesity ([@c122]) and acute myeloid leukemia ([@c77]), whereas in EWAS, cg26704043 was associated with systemic lupus erythematosus ([@c58]) and Grave's disease ([@c22]). These findings highlight the role of DNA methylation changes in these genes as potential mechanisms by which railway noise and ${PM}_{2.5}$ contribute to the resulting inflammatory and neurological phenotypes.

Our observation of numerous independent DMRs (for all five exposures), despite paucity of single CpG signals, highlights the relevance of concurrent investigation of genomic regions in EWAS. Analyses of genomic regions contextualize CpGs to identify DMRs with possible functional relevance in regulation of gene transcription ([@c96]). It is interesting to note that transportation noise showed mostly decreased methylation, whereas air pollution showed mostly increased methylation at the respective DMRs. This difference in direction of association was also observed at the levels overlapping CpGs and annotated DMRs. The relevance of these findings remains to be clarified because DNA hypermethylation is often associated with transcriptional gene repression, whereas hypomethylation is associated with a chromatin configuration that allows transcription ([@c102]). However, concordant hypermethylation in *TRIM39* (railway noise and ${PM}_{2.5}$) and *HOXA2* (aircraft noise and ${PM}_{2.5}$) and hypomethylation in *SLC27A3* and *EN2* (railway and road traffic noise) protein-coding genes indicate some synergistic pathways between exposures. *TRIM39* activates the apoptotic signaling pathway and plays a role in cellular signaling and response to stimuli ([@c126]), and its hypermethylation was associated with depression ([@c26]). *HOXA2* encodes a transcriptional regulator that controls cellular differentiation during development ([@c5]). Hypermethylation at this gene was associated transcriptional suppression in various cancers ([@c71]). *SLC27A3* is involved in lipid metabolism and brain development ([@c108]), and hypomethylation in this gene was associated with recurrent endometrial carcinoma ([@c56]). *EN2* functions in the development of the central nervous system and is commonly associated with autism ([@c76]; [@c78]). Aberrant methylation in *EN2* was recently linked to clear cell renal carcinoma ([@c66]). Although these highlight certain distinct and shared pattern of associations, they demonstrate the complex network in the mechanisms linking these exposures to disease. The integration of gene expression or transcriptomic data in future studies will improve our understanding of the mechanisms going from divergence in directions of associations to convergence on pathway levels across these exposures.

The results demonstrating enrichment for DNA methylation associated with phenotypes of "allostatic load" for both air pollution and noise exposure are novel but in line with previously hypothesized mechanisms. Chronic low-level exposure to air pollution and noise are established risk factors for cardio-metabolic disease and were previously linked to the single phenotypes making up the "allostatic load" pathway in this study ([@c82]; [@c111]). Recent experimental evidence specifically linked PM and ozone pollution as well as transportation noise to alterations in the HPA axis ([@c59]). The findings of "allostatic load" enrichment agree with the functional enrichment of pathways related to oxidative stress and immune responses across all exposures. Furthermore, the enriched disease networks identified for ${PM}_{2.5}$ overlaps the networks that were recently reported for ${PM}_{10}$ in another study ([@c68]). Taken together, the evidence especially supports the recent links of transportation noise to markers of inflammation and oxidative stress ([@c12]; [@c83], [@c84]; [@c82]). However, our findings on the inflammatory pathway might have been influenced by the higher prevalence of asthma in this sample (22%) in comparison with that of the entire SAPALDIA study (12%), but our models contained asthma status in addition to smoking and pack-years and should minimize this potential bias. In line with recent evidence on the early-life methylome effects of air pollution ([@c17]; [@c46]) and potentially noise exposures, we observed enrichment of pathways related to embryonic and organ development for all exposures. Altered DNA methylation due to these exposures might therefore explain the reported associations of PM and poor birth outcomes ([@c75]; [@c106]), as well as the early-life theory of age-related disease ([@c120]). This finding is even more relevant if these methylation changes are heritable and, when confirmed, improves our understanding of the relevance of this pathway in relation to these exposures.

The relevance of confounding by leukocyte composition on the association between exposures and peripheral blood DNA methylation has been of interest ([@c50]; [@c116]). In post hoc analyses, we demonstrated the general weakening of top CpGs (with some signals not attaining nominal significance) when leukocyte composition was not considered. However, main effect sizes remained robust (Table S7). Source-specific transportation noise and air pollution exposures were also associated with various leukocyte types (Table S8). These associations indicate that changes in leukocyte composition probably drive methylation at certain sites and should be considered potential confounders in this and similar studies. Our findings in this EWAS (adjusted for leukocyte composition) are more likely to reflect actual DNA methylation changes rather than the underlying leukocyte composition changes in relation to transportation noise and air pollution exposure. This finding would otherwise be difficult to interpret, given the observed associations of exposures with leukocyte types.

The strengths of our study include being the first EWAS to assess mutually independent effects of source-specific transportation noise and air pollution exposures. Our study considered in parallel the independent effects of these exposures on DNA methylation at single CpG sites and in genomic regions. The availability of individually assigned, source-specific noise and air pollution data, derived from validated models, allowed the exploration of mutual confounding of these exposures on DNA methylation. We were able to control for potential confounders given the detailed characterization of the participants in the SAPALDIA study. The multiexposure approach also allowed the investigation of the independent pathway enrichment using both candidate and agnostic approaches to improve mechanistic understanding of transportation noise and air pollution exposures. We used a novel approach to investigate indirectly the effect of these exposures on physiological stress systems. We could also explore the influence of leukocyte composition, among other sensitivity analyses. The availability of genome-wide methylation data allowed the validation of previously reported air pollution signals, contributing to their external validity in the SAPALDIA study.

Our study is limited in its cross-sectional design, which precludes causal inferences and differentiating short-term vs. long-term exposure effects. Our noise and air pollution estimates may have been biased by errors in input data, which could be exposure-specific and potentially account for variations in observed effects. Such bias, however, would most likely be nonsystematic and nondifferential. The air pollution and noise levels in the SAPALDIA study are relatively low and may have reduced statistical power of identifying signals and limited the replication of previous findings in settings of higher exposure. Unlike road traffic noise, which was ubiquitous, railway and aircraft noise in the SAPALDIA study were less common, with only $\sim 45\%$ exposure to these sources. Nevertheless, we made some significant observations. We could not identify any EWAS on stress hormones that directly captured alterations in the HPA axis; thus, our definition of "allostatic load" may have been biased. However, we expect any bias to be minimal, given our inclusion of CAR and other downstream biomarkers of physiological stress. As demonstrated in a recent review ([@c62]), there is yet no consensus on which markers best capture "allostatic load." We find it interesting that "allostatic load" score was always associated with negative health outcomes regardless of constituent biomarkers or phenotypes ([@c18]; [@c62]; [@c98]).

Conclusions {#s5}
===========

DNA methylation was independently associated with transportation-related noise and air pollution exposures in the SAPALDIA study, with enrichment for pathways related to inflammation and immune response. Differential methylation due to these exposures may therefore explain the link between these exposures and several age-related outcomes. More EWAS with combined exposures and gene expression or transcriptome data are needed, especially from more polluted areas (including low- and middle-income countries), to corroborate present findings and to better capture the full extent and relevance of DNA methylation changes associated with these exposures. In particular, it remains to be seen if DNA methylation related to the identified pathways mediates the association between transportation noise and air pollution exposures and incident age-related phenotypes.
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